Star Scientific Shareholders Sue Over Drug Claims

Law360, New York (May 10, 2013, 6:39 PM EDT) -- Star Scientific and its board of directors Thursday were slapped with a derivative shareholder action in Virginia federal court alleging the company falsely linked John Hopkins University to one of its clinical tests and delayed releasing information about a federal investigation of the company.

The action joined at least three similar suits filed in the last two months accusing the supplement company of artificially inflating stock prices by lying and withholding information. The company allegedly lied to investors about John Hopkins University's role in clinical testing...
To view the full article, register now.